Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway. (Q42725443)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 2012

Language	Label	Description	Also known as
English	Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway.	scientific article published on March 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Jung-Sun Kim

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Il-Kwon Kim

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Se-Yeon Lee

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Byeong-Wook Song

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Min-Ji Cha

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Heesang Song

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Eunmi Choi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Soyeon Lim

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Onju Ham

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ki-Chul Hwang

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 March 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Cell Biology International

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

305-310

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Peroxisome proliferator-activated receptor gamma regulates angiotensin II-stimulated phosphatidylinositol 3-kinase and mitogen-activated protein kinase in blood vessels in vivo

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Thiazolidinedione regulation of smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Antiproliferative mechanisms of raxofelast (IRFI-016) in H2O2-stimulated rat aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Angiotensin IV enhances phosphorylation of 4EBP1 by multiple signaling events in lung endothelial cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

The renin-angiotensin system and vascular hypertrophy

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Identifiers

10.1042/CBI20100524

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42725443&oldid=1581910421"